A comparison of acute lymphoblastic leukemia in down syndrome and non- down syndrome children: The role of trisomy 21

Journal of Pediatric Oncology Nursing

Volumn 26, Issue 6, 2009, Pages 362-368

  Tigay, Judith Harriet ^a  

^a UNIVERSITY OF MICHIGAN FLINT   (United States)

Author keywords

All; Down syndrome; Trisomy 21

Indexed keywords

TRANSCRIPTION FACTOR GATA 1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CASE REPORT; CHILD; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DOWN SYNDROME; FEMALE; GENETICS; HUMAN; MUTATION; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS;

CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DOWN SYNDROME; FEMALE; GATA1 TRANSCRIPTION FACTOR; HUMANS; MUTATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS;

EID: 73249114077     PISSN: 10434542     EISSN: 15328457     Source Type: Journal    
DOI: 10.1177/1043454209340321     Document Type: Article

References (22)

1. Arico, M., Ziino, O., Valsecchi, M.G., & Cazzaniga, C.B. (2008). Acute lymphoblastic leukemia and Down syndrome. Cancer, 113, 515-521.
2. Arya, L.S. (2004). Acute lymphoblastic leukemia: Current therapy. Indian Journal of Medical and Pediatric Oncology, 25, 11-17.
3. Bercovich, D., Ganmore, I., Scott, L.M., Wainrib, G., Birger, Y., Elimelich, A.,et al.(2008). Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down syndrome. Lancet, 372, 1484-1492.
4. Chen, H. (2007). Down syndrome. Retrieved November 14, 2008, from http://www.emedicine.com/ped/TOPIC615.HTM.
5. Chessells, J.M., Harrison, G., Richards, S.M., Bailey, C.C., Hill, F.G.H., Gibson, B.E.,et al.(2001). Down's syndrome and acute lymphoblastic leukaemia: Clinical features and response to treatment. Archives of Disease in Childhood, 81, 321-325.
6. Dixon, N., Kishnani, P.N., & Zimmerman, S. (2006). Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, 142, 149-157.
7. Fuerst, M. (2008). Activating mutations in JAK2 collaborate in Down syndrome ALL. Oncology Times, 30, 57-58.
8. Hargrave, D.R., Hann, I.I., Richards, S.M., Lilleyman, J.S., Kinsey, S., Bailey, C.C.,et al.(2001). Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukemia deaths from 1980 to 1987 (UKALL VIII, X and XI). British Journal of Haematology, 112, 293-299.
9. Izraeli, S., Rainis, L., Herzberg, L., Smooha, G., & Birger, Y. (2008). Trisomy of 21 in leukomogenesis. Blood Cells, Molecules and Disease, 39, 156-159.
10. Kuchinskaya, E. (2007). Genetic studies of acute lymphoblastic leukemia. Unpublished doctoral dissertation, Karolinska Institutet, Stockholm, Sweden.
11. Ma, S.K., Wan, T.S.K., Cheuk, A.T.C., Fung, L.F., Chan, G.C.F., Chan, S.Y.,et al.(2001). Characteristics of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: A molecular cytogenics study. Leukemia, 15, 1442-1447.
12. Malinge, S., Ben-Abdelali, R., Settegrana, C., Radford-Weiss, I., Debre, M., Beldjord, K.,et al.(2007). Novel activating mutation in a patient with Down syndrome and B cell precursor acute lymphoblastic leukemia. Blood, 109, 2202-2204.
13. PDQ. National Cancer Institute's (NCI's) comprehensive cancer information database. Leukemia, acute lymphoblastic, adult: Treatment. (2008) Patient Information, National Cancer Institute, Retrieved June 23, 2009 from http://www.everettclinic.com/kbase/nci/ncicdr0000257989.htm.
14. Ozyurek, H., Turker, H., Akbalik, M., Bayrak, A.O., Ince, H., & Duru, F. (2007). Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy. Pediatric Hematologic Oncology, 24, 447-452.
15. Steiner, M., Attarbaschi, A., Konig, M., Gadner, H., Haas, O., & Mann, G. (2004). Equal frequency of TEL/AMI1 acute lymphoblastic leukemia in children with and without Down syndrome. Pediatric Hematology and Oncology, 22, 11-16.
16. Tsuzuki, S., Karnan, S., Horibe, K., Matsumoto, K., Kato, K., Inukai, T.,et al.(2007). Genetic abnormalities in t(21) TEL/ AML1 acute lymphoblastic leukemia: Analysis by means of array-based comparative genomic hybridization. Cancer, 98, 699-706.
17. Tzortzatou-Stathapoulou, F., Papadopoulou, A.L., Moschovi, M., Botsanis, A., & Tsangaris, G.T. (2001). Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy. Pediatric Hematologic Oncology, 23, 591-597.
18. Webb, D., Roberts, I., & Vyas, P. (2007). Haematology of Down syndrome. Archives of Diseases in Childhood-Fetal and Neonatal Edition, 92, F503-F507.
19. Whitlock, J. (2006). Down syndrome and acute lymphoblastic leukemia. British Journal of Haematology, 135(5), 595-602.
20. Whitlock, J.A., Sather, H.N., Gaynon, P., Robison, L., Wells, R.J., Michael, H.,et al.(2005). Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: A children's Cancer Group study. Blood, 106, 4043-4049.
21. Woo, H.Y., Kim, D.W., Park, H., Seong, K.W., Koo, H.H., & Kim, S.H. (2005). Molecular cytogenic arrangements of gene rearrangements in childhood acute lymphoblastic leukemia. Journal of Korean Medicine and Science, 20, 36-41.
22. Zeller, B., Gustafsson, G., Forestier, E., Abrahamsson, J., Clausen, N., Heldrup, J.,et al.(2005). Acute leukaemia in children with Down syndrome: A population-based Nordic study. British Journal of Haematology, 128, 797-804.